Endothelin receptor antagonist bosentan improves survival in a murine caecal ligation and puncture model of septic shock

European Journal of Pharmacology

Volumn 506, Issue 1, 2004, Pages 83-88

  Iskit, Alper B ^a   Senel, Isil ^a   Sokmensuer, Cenk ^a   Guc, M Oguz ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Bosentan; Endothelin; Organ injury; Septic shock; Survival

Indexed keywords

BOSENTAN; ENDOTHELIN; ENDOTHELIN RECEPTOR ANTAGONIST; PEPTIDE; SODIUM CHLORIDE; SOLVENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR RESPONSE; CECUM; CECUM DISEASE; CLINICAL OBSERVATION; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; EXPERIMENTAL MODEL; HISTOPATHOLOGY; INJECTION; KIDNEY; LIGATION; LIVER; MOUSE; NONHUMAN; ORGAN INJURY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PUNCTURE; RECORDING; RESUSCITATION; SEPTIC SHOCK; SPLEEN; SURVIVAL; SURVIVAL RATE; SURVIVAL TIME; TIME; TISSUE INJURY;

ANIMALS; ANTIHYPERTENSIVE AGENTS; CECUM; DISEASE MODELS, ANIMAL; KIDNEY; LIGATION; LIVER; MICE; RECEPTORS, ENDOTHELIN; SHOCK, SEPTIC; SODIUM CHLORIDE; SPLEEN; SULFONAMIDES; SURVIVAL RATE; TIME FACTORS; WOUNDS AND INJURIES;

EID: 9644281471     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.10.038     Document Type: Article

References (26)

1. M. Albertini, B. Ciminaghi, S. Mazzola, and M.G. Clement Improvement of respiratory function by bosentan during endotoxic shock in the pig Prostaglandins Leukot. Essent. 65 2001 103 108
2. C.C. Baker, I.H. Chaudry, H.O. Gaines, and A.E. Baue Evaluation of factors affecting mortality rate after sepsis in murine cecal ligation and puncture model Surgery 94 1983 331 335
3. R.C. Bone The pathogenesis of sepsis Ann. Intern. Med. 115 1991 457 469
4. J.S. Brauner, L.E. Rohde, and N. Clausell Circulating endothelin-1 and tumor necrosis factor alpha: early predictors of mortality in patients with septic shock Intensive Care Med. 26 2000 305 313
5. I.H. Chaudry, K.A. Wichterman, and A.E. Baue Effect of sepsis on tissue adenine nucleotide levels Surgery 85 1979 205 211
6. M. Clozel, V. Breu, G.A. Gray, B. Kalina, B.-M. Loffer, K. Burri, J.M. Cassal, G. Hirth, M. Muller, W. Neidhart, and H. Ramuz Pharmacological characterization of bosentan, a new potent orally active non-peptide endothelin receptor antagonist J. Pharmacol. Exp. Ther. 270 1994 228 235
7. S.M. Gardiner, P.A. Kemp, and J.E. March Enhancement of the hypotensive and vasodilator effects of endotoxaemia in conscious rats by the endothelin antagonist, SB 209670 Br. J. Pharmacol. 116 1995 1718 1719
8. A.B. Iskit, and M.O. Guc Timing of endothelin and nitric oxide inhibition is crucial for survival in septic shock Br. J. Surg. 87 2000 937
9. A.B. Iskit, and M.O. Guc The timing of endothelin and nitric oxide inhibition affects survival in a mice model of septic shock Eur. J. Pharmacol. 414 2001 281 287
10. A.B. Iskit, and M.O. Guc Effects of endothelin and nitric oxide on organ injury, mesenteric ischemia, and survival in experimental models of septic shock Acta Pharmacol. Sin. 24 2003 953 957
11. A.B. Iskit, and M.O. Guc A new therapeutic approach for the treatment of sepsis Med. Hypotheses 62 2004 342 345
12. A.B. Iskit, A. Sungur, G. Gedikoglu, and M.O. Guc The effects of bosentan, aminoguanidine and l-canavanine on mesenteric blood flow, spleen and liver in endotoxaemic mice Eur. J. Pharmacol. 379 1999 73 80
13. B. Kavuklu, A.B. Iskit, M.O. Guc, M. Ilhan, and I. Sayek Aminoguanidine attenuates endotoxin-induced mesenteric vascular hyporeactivity Br. J. Surg. 87 2000 448 453
14. M.M. Parker, J.H. Shelhamer, C. Natanson, D.W. Alling, and J.E. Parrillo Serial cardiovascular variables in survivors and non-survivors of human septic shock: heart rate as an early predictor of prognosis Crit. Care Med. 15 1987 923 929
15. M.S. Rangel-Frausto, D. Pittet, M. Costigan, T. Hwang, C. Davis, and R.P. Wenzel The natural history of the systemic inflammatory response syndrome (SIRS) J. Am. Med. Assoc. 273 1995 117 123
16. D. Remick, P. Manohar, G. Bolgos, J. Rodriguez, L. Moldawer, and G. Wollenberg Blockade of tumor necrosis factor reduces lipopolysaccharide lethality, but not the lethality of cecal ligation and puncture Shock 4 1995 89 95
17. H. Ruetten, C. Thiemermann, and J.R. Vane Effects of endothelin receptor antagonist, SB209670, on circulatory failure and organ injury in endotoxic shock in the anaesthetized rat Br. J. Pharmacol. 118 1996 198 204
18. M. Sugiura, T. Inagami, and V. Kon Endotoxin stimulates endothelin-release in vivo and in vitro as determined by radioimmunoassay Biochem. Biophys. Res. Commun. 161 1989 1220 1227
19. P. Villa, G. Sartor, M. Angelini, M. Sironi, M. Conni, P. Gnocchi, A.M. Isetta, G. Grau, W. Buurman, and L.J. van Tits Pattern of cytokines and pharmacomodulation in sepsis induced by cecal ligation and puncture compared with that induced by endotoxin Clin. Diagn. Lab. Immunol. 2 1995 549 553
20. O.F. Wagner, G. Christ, J. Wojta, H. Vierhapper, S. Parzer, P.J. Nowotny, B. Schneider, W. Waldhausl, and B.R. Binder Polar secretion of endothelin-1 by cultured endothelial cells J. Biol. Chem. 267 1992 16066 16068
21. M. Wanecek, E. Weitzberg, A. Rudehill, and A. Oldner The endothelin system in septic and endotoxin shock Eur. J. Pharmacol. 407 2000 1 15
22. P. Wang, and I.H. Chaudry Mechanism of hepatocellular dysfunction during hyperdynamic sepsis Am. J. Physiol. 270 1996 R927 R938
23. P. Wang, Z.F. Ba, and I.H. Chaudry Increase in hepatic blood flow during early sepsis is due to increased portal blood flow Am. J. Physiol. 261 1991 R1507 R1512
24. E. Weitzberg, J.M. Lundberg, and A. Rudehill Elevated plasma levels of endothelin in patients with sepsis syndrome Circ. Shock 33 1991 222 227
25. K.A. Wichterman, A.E. Baue, and I.H. Chaudry Sepsis and septic shock: a review of laboratory models and a proposal J. Surg. Res. 29 1980 189 201
26. S. Yang, C.S. Chung, A. Ayala, I.H. Chaudry, and P. Wang Differential alterations in cardiovascular responses during the progression of polymicrobial sepsis in the mouse Shock 17 2002 55 60